|
Title
|
|
|
|
Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluorouracil (CMF) as first-line treatment of MBC
| |
|
Author
|
|
|
|
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Anti-cancer drugs: an international journal on anti-cancer agents. - Philadelphia, Pa
| |
|
Publication
|
|
|
|
Philadelphia, Pa
:
2005
| |
|
ISSN
|
|
|
|
0959-4973
| |
|
DOI
|
|
|
|
10.1097/01.CAD.0000175587.31940.19
| |
|
Volume/pages
|
|
|
|
16
:8
(2005)
, p. 871-877
| |
|
ISI
|
|
|
|
000231867800011
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|